Skip to main content
. 2018 Feb 5;10:1758834018755072. doi: 10.1177/1758834018755072

Figure 1.

Figure 1.

Fluctuations in utility values and QoL scores in four domains after first-line treatment with afatinib versus gefitinib. The colored shadow illustrates a 95% confidence interval for each function.

QoL, quality of life.